Abstract
Background COVID-19 pandemic has affected all countries across the globe in varying intensity resulting in varied numbers for total cases and deaths.
Objectives The paper aims to understand if different socioeconomic factors have a role to play in determining the intensity of COVID-19 impact.
Methods The study uses a country-wise number of corona cases and deaths and analyse them in a cross-country multivariate regression framework. It uses gross domestic product per capita, average temperature, population density, and median age as independent variables. The study uses testing data as a control variable.
Results In absence of the testing variable, higher-income countries have experienced a higher number of COVID cases. The population density, median age, climate do not have significant impact. The countries with higher population density have lower deaths. Each region shows different patterns of correlation between socioeconomic factors and COVID intensity.
Conclusion The majority of the cross-country variation can be attributed to the number of tests done by a country. The countries with high population density would have applied strict lockdowns and proactive testing to curb the deaths. The study essentially refutes claims around corona being a high-income group disease, cold-climate disease, or a disease impacting old-age patients more.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Not applicable as this is a secondary data based research and not a clinical trial
Funding Statement
No funding was required.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Exempted as the study is based on secondary publicly published data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We do not wish to make data public as all the data used is readily available in public domain.
